IBS Flashcards
Signs and symptoms of IBS
Chronic abdominal pain with altered bowel habits (diarrhea or constipation), bloating
Rome IV criteria for IBS
Chronic abdominal pain at least 1 day/week in the last 3 months AND AT LEAST 2 OF THE FOLLOWING:
Associated with defecation
Change in stool frequency
Change in form/appearance of stool
Does IBS affect women or men more?
Women <50 years old
Etiologies of IBS
Genetics, motility factors, colonic infections (gastroenteritis), bowel flora overgrowth, psychological stress
Complications: IBS-C
Bristol Stool Chart: >25% of types 1 and 2, <25% of types 6 and 7
Complications: IBS-D
Bristol Stool Chart: >25% of types 6 and 7, <25% of types 1 and 2
Complications: IBS-M
Bristol Stool Chart: >25% of types 1, 2, 6, and 7
IBS treatment goals
Improve stool frequency and consistency, improve global symptoms
Treatment options for IBS-C
Lubiprostone (Amitiza)
Linaclotide (Linzess)
Plecanatide (Trulance)
Tegaserod (Zelnorm)
Lubiprostone is approved for IBS-C in what patients?
WOMEN ONLY
Lubiprostone dosing
8mg BID WITH FOOD
Lubiprostone side effects
Diarrhea and nausea
Secretagogue medications
Linaclotide (Linzess) and plecanatide (Trulance)
Linaclotide dosing
290mcg PO QD
Plecanatide dosing
3mg PO QD
ADE of linaclotide and plecanatide
Diarrhea (Linzess more than Trulance)